← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 12, 2018Last known activity
Sep 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 5 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT07159152OfficialN/ASep 1, 2025
- NCT05069246Lead sponsorPhase 2Dec 8, 2020
- NCT05069246Sponsor investigatorPhase 2Dec 8, 2020
- NCT05069246Study directorPhase 2Dec 8, 2020
- NCT04387240Overall official - principal investigatorPhase 2Jun 30, 2020
- NCT04387240Lead sponsorPhase 2Jun 30, 2020
- NCT04387240Reponsible party - principal investigatorPhase 2Jun 30, 2020
- NCT04476069Overall official - principal investigatorPhase 3Jan 10, 2019
- NCT04476069Reponsible party - principal investigatorPhase 3Jan 10, 2019
- NCT04476069Lead sponsorPhase 3Jan 10, 2019
- NCT04654624CollaboratorPhase 2/Phase 3Oct 12, 2018
Details
- Last known activity
- Sep 1, 2025